Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: A Meta-Analysis With Reconstructed Individual Patient Data (P4-20.010)
Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: A Meta-Analysis With Reconstructed Individual Patient Data (P4-20.010)
Abstract
To compare the efficacy and safety of Bruton's tyrosine kinase (BTK) inhibitors against placebo and teriflunomide in patients with Multiple Sclerosis (MS).
Description
Keywords
Medicine, Kinase, Patient Data, Cancer Research, Tyrosine Kinase
Fields of Science
Citation
WoS Q
Scopus Q
Source
Volume
106
Issue
11_Supplement_1
